Research Article
Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
Table 2
CD47 expression in endometrial cancer with different clinicopathological variables using TCGA dada.
| | Characteristics | Low expression of CD47 (%) | High expression of CD47 (%) | P value |
| | n | 276 | 276 | | | Age, mean ± SD | 62.04 ± 11.79 | 66.12 ± 9.9 | | | Clinical stage | | | 0.024 | | Stages I + II | 209 (37.8%) | 184 (33.3%) | | | Stages III + IV | 57 (12.1%) | 92 (16.7%) | | | Age | | | <0.001 | | ≤60 | 126 (23%) | 80 (14.6%) | | | >60 | 149 (27.1%) | 194 (35.3%) | | | Weight (Kg) | | | 0.057 | | ≤80 | 111 (21%) | 132 (25%) | | | >80 | 155 (29.4%) | 130 (24.6%) | | | Height (cm) | | | 0.364 | | ≤160 | 119 (22.8%) | 128 (24.5%) | | | >160 | 145 (27.7%) | 131 (25%) | | | BMI | | | 0.730 | | ≤30 | 105 (20.2%) | 107 (20.6%) | | | >30 | 158 (30.4%) | 149 (28.7%) | | | Histological type | | | <0.001 | | Endometrioid | 245 (44.4%) | 165 (29.9%) | | | Mixed | 9 (1.6%) | 15 (2.7%) | | | Serous | 22 (4%) | 96 (17.4%) | | | Histologic grade | | | <0.001 | | G1 | 60 (11.1%) | 38 (7%) | | | G2 | 73 (13.5%) | 47 (8.7%) | | | G3 | 141 (26.1%) | 182 (33.6%) | | | Tumor invasion (%) | | | 0.882 | | <50 | 139 (29.3%) | 120 (25.3%) | | | ≥50 | 113 (23.8%) | 102 (21.5%) | | | Menopause status | | | 0.002 | | Pre | 27 (5.3%) | 8 (1.6%) | | | Peri | 11 (2.2%) | 6 (1.2%) | | | Post | 216 (42.7%) | 238 (47%) | | | Hormones therapy | | | 1.000 | | No | 148 (43%) | 149 (43.3%) | | | Yes | 23 (6.7%) | 24 (7%) | |
|
|
